Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Rongwudi Pharmaceutical Technology is a specialized Chinese firm dedicated to the research, development, and technical transfer of pharmaceutical intermediates and fine chemicals. Headquartered in the Shijiazhuang High-tech Industrial Development Zone, the company provides contract research and customized synthesis services tailored to the needs of the global pharmaceutical industry. Their core expertise lies in the development of efficient synthetic pathways for complex organic molecules, particularly those used as intermediates for targeted oncology therapies like kinase inhibitors. Rongwudi operates as a strategic technology partner, assisting pharmaceutical companies in optimizing their chemical processes and scaling up production from laboratory to commercial levels. The company's portfolio includes technical solutions for the synthesis of active pharmaceutical ingredients (APIs) across various therapeutic categories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Rongwudi Pharmaceutical Technology.